Firpi RJ et al. |
Sirolimus-induced hyperlipidaemia in liver transplant recipients is not dose-dependent. |
2004 |
Aliment. Pharmacol. Ther. |
pmid:15113371
|
Herrlinger KR et al. |
Infliximab as rescue medication for patients with severe ulcerative/indeterminate colitis refractory to tacrolimus. |
2010 |
Aliment. Pharmacol. Ther. |
pmid:20175769
|
Schwrer H et al. |
Pantoprazole and cyclosporine or tacrolimus. |
2001 |
Aliment. Pharmacol. Ther. |
pmid:11284790
|
Trotter JF et al. |
Effect of hepatitis C infection on tacrolimus doses and blood levels in liver transplantation recipients. |
2005 |
Aliment. Pharmacol. Ther. |
pmid:15963078
|
Lawrance IC and Copeland TS |
Rectal tacrolimus in the treatment of resistant ulcerative proctitis. |
2008 |
Aliment. Pharmacol. Ther. |
pmid:18761706
|
Liberal R et al. |
Expert clinical management of autoimmune hepatitis in the real world. |
2017 |
Aliment. Pharmacol. Ther. |
pmid:28004405
|
Segal JP et al. |
Systematic review with meta-analysis: the management of chronic refractory pouchitis with an evidence-based treatment algorithm. |
2017 |
Aliment. Pharmacol. Ther. |
pmid:28008631
|
Yamamoto T et al. |
Editorial: tacrolimus vs. anti-tumour necrosis factor agents for moderately to severely active ulcerative colitis--authors' reply. |
2016 |
Aliment. Pharmacol. Ther. |
pmid:27040167
|
Taylor KM and Sparrow MP |
Editorial: tacrolimus vs. anti-tumour necrosis factor agents for moderately to severely active ulcerative colitis. |
2016 |
Aliment. Pharmacol. Ther. |
pmid:27040166
|
Nakase H et al. |
Cytomegalovirus affects clinical outcome of infliximab in ulcerative colitis refractory to tacrolimus. |
2010 |
Aliment. Pharmacol. Ther. |
pmid:20636704
|